Ornithobacterium rhinotracheale (ORT): A Comprehensive Guide to Respiratory Disease in Poultry
By Dr. Zubair Khalid, DVM, MS, PhD ·

Key Takeaways
- Ornithobacterium rhinotracheale (ORT) is a Gram-negative bacterium causing significant respiratory disease (ornithobacteriosis) in turkeys and chickens, leading to economic losses through mortality, reduced growth, and condemnations.
- The primary route of ORT infection is inhalation of contaminated aerosols, with pathogenesis involving adherence to the respiratory epithelium, biofilm formation, and production of virulence factors, often exacerbated by coinfections with other avian pathogens.
- Diagnosis relies on a combination of bacterial culture and isolation from respiratory tissues, molecular methods such as conventional and real-time PCR, and serological tests like ELISA for antibody detection.
- ORT isolates frequently exhibit multidrug resistance (MDR), with high resistance rates to tetracyclines and increasing resistance to fluoroquinolones, necessitating antimicrobial susceptibility testing for effective treatment.
- Control strategies include stringent biosecurity measures, effective ventilation management, vaccination with inactivated or autogenous bacterins (efficacy varies by serotype), and proactive management of coinfecting viral and mycoplasma pathogens.
- Clinical signs in chickens include coughing, sneezing, and conjunctivitis, while turkeys often present with depression, gasping, and severe airsacculitis, leading to high condemnation rates at slaughter.
Introduction
Ornithobacterium rhinotracheale (ORT) is a Gram-negative, rod-shaped, non-spore-forming bacterium that causes ornithobacteriosis, an emerging respiratory disease in commercial poultry worldwide. The pathogen primarily affects turkeys and chickens but has been isolated from many avian species including pigeons, ducks, geese, pheasants, and wild birds. ORT infection contributes to substantial economic losses through increased mortality, reduced weight gain, slaughterhouse condemnations due to airsacculitis, and costs associated with treatment and control measures [<a href="#ref-1">1</a>, <a href="#ref-2">2</a>].
This article provides a comprehensive review of ORT, focusing on its etiological characteristics, pathogenesis, clinical manifestations, diagnostic approaches, antimicrobial resistance patterns, treatment options, control strategies, and economic impact.
Etiology and Taxonomy
ORT belongs to the family Weeksellaceae within the phylum Bacteroidetes. The bacterium is pleomorphic, appearing as rod-shaped or filamentous cells, and is 0.2-0.7 μm wide by 1-3 μm long. It is non-motile, catalase-negative, oxidase-positive, and requires a microaerophilic to capnophilic atmosphere for optimal growth. ORT colonies on blood agar are small (0.5-1 mm), convex, grayish, and may produce a characteristic sweetish odor. The organism does not grow on MacConkey agar.
The genome of ORT is approximately 2.3-2.6 Mb in size with a G+C content of 35-37% [<a href="#ref-3">3</a>, <a href="#ref-4">4</a>]. Whole-genome sequencing and comparative genomics have revealed significant genetic diversity among ORT isolates, driven by recombination and horizontal gene transfer [<a href="#ref-3">3</a>, <a href="#ref-5">5</a>, <a href="#ref-6">6</a>]. Multilocus sequence typing (MLST) and 16S rRNA gene analysis have been used to classify ORT into distinct phylogenetic clusters.
Serotyping
ORT isolates are classified into at least 18 serotypes (A through R) based on differences in outer membrane proteins and lipopolysaccharide composition. Serotypes A, B, C, D, E, and F are most commonly reported in poultry, with serotype A predominant in chickens and serotype C in turkeys, although geographic variation exists [<a href="#ref-7">7</a>]. In a study on ORT isolates from turkeys in Poland, serotypes A and C were dominant [<a href="#ref-7">7</a>]. Serotype distribution may influence vaccine efficacy and diagnostic test performance.
Pathogenesis
The primary route of ORT infection is inhalation of contaminated aerosols or dust particles. The bacterium adheres to the respiratory epithelium via fimbriae and other adhesins, followed by colonization of the trachea, air sacs, and lungs. ORT produces several virulence factors, including:
- Biofilm formation: Enhances persistence in the respiratory tract and resistance to antimicrobial agents.
- Hemagglutinins: Facilitate attachment to host cells.
- Neuraminidase: May degrade mucus and promote tissue invasion.
- Sulfonolipids (e.g., capnine): Involved in gliding motility and membrane integrity, though their exact role in ORT pathogenesis remains under investigation.
The host inflammatory response contributes to tissue damage. Infiltration of heterophils and macrophages leads to exudative inflammation, fibrin deposition, and the formation of caseous plugs in airways. Severe cases progress to airsacculitis, pneumonia, and pericarditis. Coinfection with other respiratory pathogens, such as avian metapneumovirus (aMPV), infectious bronchitis virus, avian influenza virus, Mycoplasma gallisepticum, Mycoplasma synoviae, Avibacterium paragallinarum, Pasteurella multocida, and Escherichia coli, substantially exacerbates disease severity [<a href="#ref-8">8</a>, <a href="#ref-9">9</a>, <a href="#ref-10">10</a>].
Clinical Signs and Pathology
The incubation period is typically 3-7 days. Clinical signs vary with host species, age, immune status, and presence of concurrent infections.
Chickens
In broilers, ORT infection often manifests as a mild to moderate respiratory disease with coughing, sneezing, nasal discharge, conjunctivitis, and swollen head syndrome. Mortality is usually low (1-10%) but can increase in the presence of complicating factors. In layers, a drop in egg production may occur. Chronic infections lead to poor growth and increased feed conversion ratio.
Turkeys
Turkeys are more susceptible to severe ORT disease. Clinical signs include depression, anorexia, tracheal rales, gasping, sinusitis, and severe airsacculitis [<a href="#ref-11">11</a>]. Mortality rates can reach 30% in untreated flocks. ORT is a leading cause of airsacculitis leading to high condemnation rates at slaughter [<a href="#ref-1">1</a>, <a href="#ref-11">11</a>].
Gross Lesions
- Fibrinous airsacculitis (especially thoracic and abdominal air sacs)
- Fibrinous pneumonia
- Tracheitis with mucus or caseous exudate
- Pericarditis
- Perihepatitis in severe cases
Histopathology
Microscopic examination reveals fibrinonecrotic inflammation with heterophil infiltration, edema, and bacterial colonies adherent to the epithelium. Type II pneumocyte hyperplasia and interstitial pneumonia are seen in chronic cases.
Diagnosis
A definitive diagnosis of ORT infection requires laboratory confirmation. A combination of culture, molecular methods, and serology is recommended.
1. Bacterial Culture and Isolation
ORT can be isolated from tracheal swabs, air sac swabs, lung tissue, or sinus exudates. Samples should be collected from acutely ill or freshly dead birds. The organism grows on 5% sheep blood agar or chocolate agar under 5-10% CO2 at 37°C for 24-48 hours. Colonies are small, gray, and non-hemolytic. Identification is based on Gram stain morphology, biochemical tests (oxidase-positive, catalase-negative, urease-negative), and commercial identification strips or MALDI-TOF mass spectrometry.
2. Molecular Detection
Conventional PCR and qPCR: Numerous PCR assays targeting the 16S rRNA gene, rpoB gene, or species-specific sequences have been developed [<a href="#ref-12">12</a>, <a href="#ref-13">13</a>]. Real-time PCR (TaqMan) offers high sensitivity and specificity and can detect ORT in clinical samples with low bacterial loads. Multiplex PCR assays allow simultaneous detection of ORT with other respiratory pathogens such as infectious laryngotracheitis virus and Avibacterium paragallinarum [<a href="#ref-13">13</a>].
Loop-mediated isothermal amplification (LAMP): This technique provides rapid, field-deployable detection, though it has been used more extensively for other avian pathogens.
Whole-genome sequencing and metagenomic approaches are increasingly used for outbreak investigations, antimicrobial resistance gene profiling, and phylogenetic studies [<a href="#ref-3">3</a>, <a href="#ref-5">5</a>, <a href="#ref-14">14</a>].
3. Serology
Enzyme-linked immunosorbent assay (ELISA) kits are commercially available for detecting anti-ORT antibodies in serum or egg yolk. Serology is useful for flock-level surveillance but has limited utility for individual bird diagnosis due to variability in antibody responses. A latex agglutination test (LAT) has been developed for rapid detection of ORT infection in turkeys [<a href="#ref-15">15</a>].
Diagnostic Decision Tree
flowchart TD
A["Respiratory disease in poultry flock"] --> B["Clinical examination & necropsy"]
B --> C{"Suspicion of ORT?"}
C -->|"Yes"| D["Collect tracheal/air sac swabs or tissue"]
D --> E["Acute cases: Culture on blood agar + PCR"]
D --> F["'Chronic cases: PCR + serology (ELISA')"]
E --> G["ORT isolation?"]
G -->|"Positive"| H["Confirm by MALDI-TOF or PCR"]
G -->|"Negative"| I["Consider other pathogens"]
F --> J["PCR positive?"]
J -->|"Yes"| K["Confirm by sequencing if needed"]
J -->|"No"| L["Serology positive?"]
L -->|"Yes"| M["Evidence of past exposure"]
L -->|"No"| N["Investigate non-ORT causes"]
H --> O["Antimicrobial susceptibility testing"]
O --> P["Select treatment based on MIC profile"]
I --> Q["Test for aMPV, IBV, MG, MS, APEC, etc."]
Antimicrobial Susceptibility and Resistance
ORT isolates frequently exhibit multidrug resistance (MDR). Common antimicrobial classes used in poultry include tetracyclines, macrolides, penicillins, phenicols, and fluoroquinolones. Resistance profiles vary geographically and over time.
| Antimicrobial Class | Common Resistance Pattern | Notes |
|---|---|---|
| Tetracyclines | High resistance (60-90%) | Widespread due to use in feed [<a href="#ref-7">7</a>] |
| Macrolides (tylosin, tilmicosin) | Variable (20-60%) | Resistance associated with ribosomal methylases [<a href="#ref-3">3</a>, <a href="#ref-6">6</a>] |
| Beta-lactams (amoxicillin, ceftiofur) | Moderate to high | Beta-lactamase production reported [<a href="#ref-16">16</a>] |
| Phenicols (florfenicol) | Low to moderate (10-30%) | Effective in some regions [<a href="#ref-7">7</a>] |
| Fluoroquinolones (enrofloxacin) | Variable (30-70%) | Resistance increasing [<a href="#ref-1">1</a>] |
The presence of integrative conjugative elements (ICEs) and plasmids carrying resistance genes has been documented [<a href="#ref-3">3</a>, <a href="#ref-6">6</a>]. Minimum inhibitory concentration (MIC) determination by broth microdilution or agar dilution is recommended for treatment guidance.
Treatment
Antimicrobial therapy should be based on susceptibility testing. Common therapeutic agents include:
- Macrolides: Tylosin, tilmicosin, gamithromycin. Gamithromycin has demonstrated favorable pharmacokinetic and pharmacodynamic properties against ORT in turkeys.
- Phenicols: Florfenicol is often effective against MDR isolates.
- Tetracyclines: Doxycycline and chlortetracycline, though resistance is prevalent.
- Fluoroquinolones: Enrofloxacin and danofloxacin, but use should be cautious due to resistance and regulatory restrictions.
Administration is typically via drinking water or feed, but oral dosing may be less effective in birds with reduced water intake. Aivlosin (a macrolide) and zinc oxide nanoparticles have been investigated for synergistic effects against ORT and Mycoplasma gallisepticum coinfection.
Control and Prevention
Biosecurity
Strict biosecurity measures are essential to prevent introduction and spread of ORT. These include all-in/all-out stocking, cleaning and disinfection of barns between flocks, control of human and equipment movement, and separation of different age groups [<a href="#ref-17">17</a>]. Airborne transmission via dust and bioaerosols is a major route, and ventilation management is critical in reducing pathogen load [<a href="#ref-17">17</a>, <a href="#ref-18">18</a>].
Vaccination
Both inactivated (bacterin) and live attenuated vaccines have been developed, but their efficacy varies by serotype. Autogenous vaccines prepared from specific field serotypes are commonly used. Studies in SPF chickens have shown that inactivated vaccines can reduce clinical signs and lesions [<a href="#ref-19">19</a>]. Oral vaccination strategies using IgY from hyperimmune egg yolk have also been explored [<a href="#ref-20">20</a>]. The use of aMPV or IBV vaccination may reduce the severity of ORT disease by preventing viral predisposing infections.
Management of Coinfections
Control of primary viral and mycoplasma infections is critical. Vaccination against aMPV, infectious bronchitis virus (IBV), Mycoplasma gallisepticum, and Avibacterium paragallinarum can lower the incidence of ORT-associated disease [<a href="#ref-21">21</a>, <a href="#ref-22">22</a>, <a href="#ref-23">23</a>, <a href="#ref-24">24</a>]. Improved gut health and immune modulation through nutritional strategies (e.g., arginine:lysine ratio, phytoncides) may also support respiratory defense [<a href="#ref-25">25</a>].
Economic Impact
ORT infection leads to significant economic losses in poultry production. Direct losses include mortality (up to 30% in turkeys), reduced growth rates, increased feed conversion, and treatment costs. Indirect losses result from slaughterhouse condemnations due to airsacculitis and reduced egg production. In the United States, ORT is one of the most commonly diagnosed respiratory pathogens in turkeys, and it has been associated with flock-level losses of millions of dollars annually [<a href="#ref-1">1</a>, <a href="#ref-2">2</a>]. In other regions such as Morocco, Iran, Poland, and New Zealand, ORT is an emerging threat with substantial impact [<a href="#ref-16">16</a>, <a href="#ref-26">26</a>, <a href="#ref-27">27</a>, <a href="#ref-28">28</a>].
Conclusions
Ornithobacterium rhinotracheale is a globally important respiratory pathogen of poultry, with turkeys and chickens being the most affected hosts. The bacterium's ability to cause severe disease, high genetic variability, and increasing antimicrobial resistance pose serious challenges for diagnosis and control. Effective management requires integrated strategies including accurate laboratory diagnosis, prudent antimicrobial use, biosecurity, vaccination where feasible, and control of coinfecting pathogens. Future research should focus on improving vaccines, understanding pathogenesis at the molecular level, and developing rapid point-of-care diagnostics.